Importation
PSM, Partners Host Fall 2019 Congressional Briefings About Counterfeit Drug Dangers
On September 24, 2019, the Partnership for Safe Medicines and 19 partner organizations held two congressional briefings about the real dangers counterfeit drugs pose to Americans, offering a clear picture of why importation cannot solve the problem of high drug prices in the U.S.:
Canada does not have enough prescription drugs to share with U.S.patients, and organized crime is poised to expand the counterfeit drug trade into the U.S. to bridge the gap without regard for the health and safety of U.S. residents. “The money to be made is far too great to worry about human life.”
[...]Myth: We are getting the same drugs Canadians take
In 2014, during a two-year period when Maine was experimenting with drug importation, the president of Maine’s Pharmacy Association purchased medications from an online pharmacy for testing. The drugs he received were not approved for the Canadian or U.S. markets. Worse, they were poor quality: two of them were the wrong strength, and the other was contaminated.
[...]Pharmacy professor: buying prescription drugs from Canada “risky in terms of quality and safety”
This editorial by C. Michael White was published in The Conversation on September 27, 2019. White is a professor and head of the Department of Pharmacy Practice for the University of Connecticut.
[...]Shepherd M (2019) New pathways for U.S. importation threaten Canadian prescription drug supply. Canadian Health Policy Journal,
This research paper is an update to The Effect Of U.S. Pharmaceutical Drug Importation On The Canadian Pharmaceutical Supply, published in 2010.
[...]Drug Importation By the Numbers
When broken down to the nuts and bolts of implementation and operational execution, current drug importation plans fall apart. Drug Importation is neither a safe nor cost-effective solution. The numbers do not lie.
[...]Cancer Center Pharmacist in Iowa Worries Drug Importation Will Harm His Patients
This editorial by Dana McDougall was published in The Waterloo Cedar Falls Courier on August 26, 2019. Mr. McDougall, Pharm.D., BCPS, is a pharmacist with the Covenant Cancer Treatment Center in Waterloo, Iowa.
[...]PSM Statement on Florida’s Submission of Irresponsible Drug Importation Concept Document
WASHINGTON (August 26, 2019) – Shabbir Imber Safdar, Executive Director of The Partnership for Safe Medicines, released the following statement in response to Florida’s submission of a drug importation concept to the U.S. Department of Health and Human Services (HHS): “Florida’s Canadian Prescription Drug Importation Concept Paper [PDF] recently submitted to HHS demonstrates that Florida…
[...]Senator McSally Meets with Experts on the Counterfeit Drug Trade
The Arizona Republic has reported that Executive Director Shabbir Safdar, along with Maricopa County Sheriff Paul Penzone, Pinal County Sheriff Mark Lamb, U.S. Drug Enforcement Administration special agent in charge Doug Coleman, and Phoenix-area pharmacist Randle House and met with U.S. Senator Martha McSally in Arizona on August 8th to seek her assistance and support for efforts to protect the U.S. prescription drug supply from counterfeit medication
[...]Canadian Physician Warns that American Drug Importation is Bad for Canada
This editorial by Dr. Charles S. Shaver was published in The Hamilton Spectator on August 11, 2019. Dr. Shaver i a practicing physician in Ottawa. He is a graduate of Princeton University and Johns Hopkins School of Medicine. Dr. Shaver is also past chair of the section on general internal medicine of the Ontario Medical Association.
[...]Canadians Concerned About US Prescription Drug Importation Proposals
John Adams of the Best Medicines Coalition, a Canadian group that represents 28 different patient organizations, has described the Trump administration’s plan to import medication from Canada as a “clear and present danger” to the Canadian prescription drug system, according to AP.
[...]